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Background: Impaired haemostasis following shock and tissue trauma is frequently detected in the trauma setting.
These changes occur early, and are associated with increased mortality. The mechanism behind trauma-induced
coagulopathy (TIC) is not clear. Several studies highlight the crucial role of fibrinogen in posttraumatic
haemorrhage. This study explores the coagulation changes in a swine model of early TIC, with emphasis on
fibrinogen levels and utilization of fibrinogen.
Methods: A total of 18 landrace pigs were anaesthetized and divided into four groups. The Trauma-Shock group
(TS) were inflicted bilateral blast femoral fractures with concomitant soft tissue injury by a high-energy rifle shot to
both hind legs, followed by controlled exsanguination. The Shock group (S) was exposed to shock by
exsanguination, whereas a third group was exposed to trauma only (T). A fourth group (C) served as control.
Physiological data, haematological measurements, blood gas analyses and conventional coagulation assays were
recorded at baseline and repeatedly over 60 minutes. Thrombelastometry were performed by means of the tissue
factor activated ExTEM assay and the platelet inhibiting FibTEM assay. Data were statistically analysed by repeated
measurements analyses method.
Results: A significant reduction of fibrinogen concentration was observed in both the TS and S groups. INR
increased significantly in the S group and differed significantly from the TS group. Maximum clot firmness (MCF) of
the ExTEM assay was significantly reduced over time in both TS and S groups. In the FibTEM assay a significant
shortening of the clotting time and an increase in MCF was observed in the TS group compared to the S group.
Conclusion: Despite a reduction in clotting capability measured by ExTEM MCF and a reduced fibrinogen
concentration, extensive tissue trauma may induce an increased fibrin based clotting activity that attenuates the
hypocoagulable tendency in exsanguinated animals.
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Disturbances of haemostasis are frequently encountered
in the trauma setting. Measured by conventional coagu-
lation tests, coagulopathy is found in 10-34% of patients
on arrival in hospital [1]. The presence of trauma-
induced coagulopathy (TIC) is associated with a four-
fold increase in mortality [2]. Loss and consumption
of coagulation factors, plasma dilution, hypothermia
and acidaemia are known to be important causes of* Correspondence: jostein.hagemo@snla.no
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reproduction in any medium, provided the orcoagulopathy [3]. However, several studies identify the
combination of hypoperfusion and tissue injury as primary
drivers of TIC prior to the onset of hypothermia and
acidaemia, and independent of iatrogenic dilution [2,4-6].
The exact pathophysiologic mechanisms contributing
to TIC are insufficiently described. Some studies suggest
that an abnormal expression of thrombomodulin on the
endothelial surface activates excessive amounts of pro-
tein C, which in turn diverts haemostasis in the di-
rection of hypocoagulability and hyperfibrinolysis [7,8].
Opponents of this theory argue that coagulopathy in
trauma is merely a fibrinolytic phenotype of dissemina-
ted intravascular coagulopathy, as can be seen in anyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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focus on endothelial cell and glycocalyx damage as cri-
tical components of TIC [10].
Regardless of the mechanism of TIC, available fibrino-
gen seems to play a pivotal role, as it is the end substrate
for fibrin formation, and subsequent clot formation [11].
Several authors advocate early fibrinogen substitution in
the massively bleeding trauma patient [12-14]. A num-
ber of retrospective studies support a 1:1 ratio of fresh
frozen plasma (FFP) to packed red blood cell (PRBC) in
massive transfusion [15-17], although this strategy may
have serious adverse effects in the post resuscitation
phase, especially in the hypercoagulable patients [18]. Fi-
brinogen concentrates and cryoprecipitate have emerged
as alternative sources, but their role in massive transfu-
sion still lacks firm evidence.
In the absence of conclusive clinical trials, a number
of animal experiments have been conducted to elucidate
the mechanisms of traumatic coagulopathy. However,
only a few of these include massive tissue injury, and a
minority describe changes in haemostasis occurring
prior to iatrogenic dilution. In this study we aim to
develop a large animal model to characterize the
immediate changes in coagulation, focusing more spe-
cifically on fibrinogen availability and utilization fol-
lowing the combination of massive tissue injury and
severe hypoperfusion.
Methods
Animals, anaesthesia and monitoring
The study was approved by the Norwegian Animal Re-
search Authority. All animals received care in strict
compliance with the Animal Welfare Act and statutes
from the Norwegian Ministry of Agriculture. The anaes-
thetic and analgesic regimen used in the study was in ac-
cordance with a current protocol for surgical training on
animals.
Landrace pigs (40–69 kg) were sedated by an in-
tramuscular injection of 0,06 mg/kg medetomidin hy-
drochloride (Clinipharm, Switzerland) and 3,0 mg/kg
tiletamin/zolazepam (Boehringer Ingelheim, Germany).
An intravenous dose of 0,2 mg/kg butorphanol tartrate
(American Home Products Corporation, USA) was ad-
ministered for analgesia. After induction, the animals
were intubated and hand-ventilated. In order to secure
adequate analgesia, a single shot of 0,15 ml/kg lidocaine
2% was administered epidurally in the lumbosacral
region. Cannulation of the left carotid artery and left
jugular vein was performed with a 16G cannula for mo-
nitoring, blood sampling and controlled exsanguination
during the experiment. Anaesthesia was maintained with
2% isofluorane (Baxter International Inc, IL, USA), and
the animals were normoventilated to a target pCO2 of
5.0-6.0 kPa with FiO2 0,5. 500 ml of normal saline wasadministered intravenously over 60 minutes from in-
duction of anaesthesia. All animals were monitored
with intra-arterial blood pressure, ECG, SpO2, and a
pharyngeal temperature probe. At the end of the ex-
periment, the animals were euthanized by an intrave-
nous dose of 4 g of Thiopental sodium (Hospira Inc.
IL, USA).Procedure
Eighteen animals were randomly divided into four groups.
One group was exposed to both trauma and haemorrhagic
shock (TS group, n = 8). One group underwent shock
without injury (S group, n =4). One group was inflicted
massive tissue injury but not exposed to shock (T group,
n = 4), and finally one group, that was only anaesthetized
and instrumented, served as control (C group, n = 2).
Tissue injury was created by two standardized high-
energy rifle shots to both hind legs, creating bilateral
blast femoral fractures with significant concomitant soft
tissue injury [19]. The wounds were packed immediately
for haemorrhage control, and an estimate of immediate
blood loss was recorded. Exsanguination was induced by
controlled extraction of blood at 1 ml/kg/min, aiming at
a total blood loss of 30 ml/kg over 30 minutes, equiva-
lent to about 45% of the estimated total blood volume
(67 ml/kg). Blood extraction was terminated if a mean
arterial pressure (MAP) < 30 mmHg was reached. If the
volume substitution in excess of the above mentioned
500 ml normal saline was required to avoid circulatory
collapse, the animal was excluded from the study.Sampling and measurements
Blood pressure, heart rate, oxygen saturation and
amount of blood extracted were recorded every 5 mi-
nutes. Blood samples were drawn at baseline (pre in-
jury), 0 minutes (immediately after injury), and after
30 and 60 minutes. Samples for haemoglobin concen-
tration (Hgb) and platelet count (Plt) were collected
in ethylenediaminetetraacetic tubes and performed on
an Advia 60 Hematology System (Bayer Healthcare
LLC, Tarrytown, NY, USA). Samples for coagulation
assays were collected in citrated tubes. Fibrinogen,
INR and aPTT assays were performed on a STA-R
Evolution analyzer (Diagnostica STAGO, Inc, Parsippany,
NJ, USA). Samples for RoTEM (TEM International
GmbH, Munich, Germany) analyses were recalcified and
activated by tissue factor in the ExTEM assay. For the
FibTEM assay platelets were inhibited by cytochalasin D,
in order to isolate the fibrin based fraction of the blood
clot. Blood for arterial blood gas analyses were collected
in heparinized syringes and analysed on an OPTI Critical
Care Analyzer AVL (Roche Diagnostics Cooperation,
Indianapolis, IN, USA).
Table 1 Physiological parameters in the four different
groups
Base line 0 minutes 30 minutes 60 minutes
MAP TS 125.3 (23.9) 71.6 (18.2)* 36.2 (3.0)*† 36.8 (5.6)*†
T 122.3 (10.3) 66.7 (8.14)* 70.3 (14.1)* 68.3 (13.5)*
S 94.8 (27.0) 44.8 (4.0)*† 53.3 (8.2)*†
C 120.0 (7.8) 85.5(7.8)* 85.0 (7.0)*
HR TS 85.3 (4.7)† 95.3 (12.1) 96.4 (12.0) 99.2 (17.6)
T 91.3 (7.0) 92.0 (10.2) 88.5 (12.1) 87.6 (13.6)
S 106.0 (12.1)† 91.8 (9.6) 92.3 (11.7)
C 101.0 (5.0) 116.0 (7.1) 106.5 (2.1)
BE TS 7.88 (2.49) 6.88 (2.44) 4.18 (4.24) 1.27 (3.63)*†
T 9.38 (5.17) 7.85 (0.72) 6.10 (2.82) 6.65 (0.65)
S 7.70 (1.43) 6.35 (1.13) 6.65 (0.65)†
C 9.30 (0.42) 10.25 (1.63) 9.00 (0.99)
TS Trauma Shock group, T Trauma group, S Shock group, C Control group,
MAP Mean arterial pressure, HR Heart rate, BE Base excess.
* indicates significant change from baseline measured by paired t-test.
† indicates significant difference between TS and S groups by
two-sample t-test.
Table 2 Haematological values and conventional
coagulation tests
Base line 0 minutes 30 minutes 60 minutes
Hgb TS 10.67 (0.57) 9.95 (0.96)* 9.15 (1.32)* 8.98 (1.26)*
T 10.65 (1.08) 9.75 (0.72) 9.58 (0.81)* 9.53 (0.46)
S 10.35 (0.66) 8.83 (0.26)* 8.65 (0.41)*
C 11.0 (0.35) 11.05 (0.35) 10.90 (0.14)
Plt TS 619.5 (149.7) 636.0 (175.1) 549.5 (119.1)* 554.7 (146.3)*
T 431.8 (110.9) 482.5 (144.5) 436.1 (76.6) 470.0 (98.6)
S 568.0 (74.7) 570.5 (29.1) 589.3 (36.2)
C 539.0 (241.8) 550.0 2410.4) 624.5 (334.5)
Fib TS 2.24 (0.73) 2.07 (0.67)* 1.76 (0.29) 1.73 (0.29)*
T 1.7 (0.07) 1.66 (0.10) 1.57 (0.11) 1.54 (0.11)
S 2.48 (0.62) 1.93 (0.45)* 1.98 (0.5)*
C 2.01 (0.04) 2.13 (0.06) 1.92 (0.07)
INR TS 0.96 (0.05) 0.94 (0.05)* 0.97 (0.06) 0.98 (0.06)
T 0.99 (0.03) 0.97 (0.03) 0.98 (0.03) 0.98 (0.02)
S 0.98 (0.02 1.03 (0.01)* 1.04 (0.03)*
C 0.98 (0.01) 0.98 (0.01) 1.00 (0.02)
aPTT TS 19.2 (1.35) 18.7 (1.14)* 19.1 (1.11) 19.5 (1.55)
T 19.5 (1.38) 19.0 (1.37) 19.1 (1.72) 19.3 (1.05)
S 22.3 (0.92) 21.9 (2.84) 22.7 (3.17)
C 21.5 (0.92) 21.3 (0.28) 22.2 (0.64)
TS Trauma Shock group, T Trauma group, S Shock group, C Control group,
Hgb Haemoglobin, Plt platelet count, Fib Fibrinogen concentration, INR
International normalized ratio, aPTT activated partial thromboplastin time.
* indicates significant change from baseline measured by paired t-test.
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Statistical analysis was performed using SAS 9.1 (SAS
Institute Inc., Cary, NC, US). Repeated-measures ana-
lyses were performed using a means model (PROC
MIXED, SAS) assuming compound symmetry covari-
ance structure among the repeated measurements.
The model included group (S group and TS group),
time (baseline, 0, 30, 60 min) and group*time effects.
The T group and C groups were not included in this
model since the primary focus of the study was to
study TIC, of which shock is a critical component.
Significant group or time effects were analyzed by two-
sample or paired post hoc t-tests. One-way ANOVA was
used for analyses of difference in body weight and total
bleeding between groups. Two-sample t-tests were used
to detect changes between groups at baseline. Data are
presented as means (SD). P-values <0.05 were considered
significant.
Results
Measurements of blood loss and shock
Of the 18 animals included in the experimental groups,
16 completed the protocol. Two animals in the TS
group were excluded due to circulatory collapse. There
were no significant differences in body weight between
groups (p = 0.590). Temperature remained above 37.2 in
all subjects, and did not change significantly from base-
line to 60 minutes in any of the groups (p = 0.134 for all
groups combined). In the TS group the mean total
amount of blood loss was 25.7% (SD: 7.9%), and did not
differ significantly from the S group with mean blood
loss 34.7% (SD: 6.9%) (p = 0.34). In the T group a mean
estimated blood loss of 4.1% (SD: 2.7%) as a direct result
of the injury was observed. Table 1 summarizes physio-
logical parameters measured in the four different groups.
Mean arterial pressure was significantly reduced after 60
minutes in all groups compared to baseline, and was sig-
nificantly lower in the TS group compared to the other
groups. Base excess was significantly reduced compared to
baseline only in the TS group, and differed significantly
from the rest of the groups.
Haematology and conventional coagulation parameters
Haemoglobin concentration and conventional coagula-
tion parameters are summarized in Table 2. In the TS
and S groups haemoglobin and fibrinogen concentra-
tions fell significantly throughout the observation period,
but did not differ significantly between the groups at any
time. INR was significantly increased compared to base-
line in the S group after 30 and 60 minutes, and also dif-
fered significantly from the TS group over time by
mixed model analyses (Figure 1). In contrast, a reduction
of both INR and aPTT compared to baseline was found
in the TS group at time 0, shortly after injury (Figure 1).
Figure 1 Changes in activated partial thromboplastin time (aPTT) (A) and international normalized ratio (INR) (B) over time for
Trauma-Shock (TS) and Shock (S) groups, with mixed-model statistical analyses. * indicates significant difference from baseline in TS group.
¤ indicates significant difference from baseline in S group. GSW: gunshot wound.
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group and differed significantly from the S group by
mixed model analyses (Figure 2).
RoTEM analyses
Mean values and standard deviation of RoTEM analyses
are given in Table 3. Due to a chance inequity of baseline
values in the different groups, values for each subject
was converted to relative values from baseline for further
statistical analyses (Table 4). The ExTEM assay showed
no significant changes in clotting time (CT). The maxi-
mum clot firmness (MCF) was significantly reduced in
both the TS and S groups compared to baseline, but at
different time points (30 and 60 minutes, respectively)
(Figure 3). After 60 minutes the MCF in the S group
was significantly lower compared to the TS group. By
mixed model analyses, changes were significant over
time, but not between the two groups.
With the added platelet inhibitor in the FibTEM assay,
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Figure 2 Changes in fibrinogen concentration (A) and Platelet count
mixed-model statistical analyses. * indicates significant difference from b
S group. GSW: gunshot wound.to baseline after 30 and 60 minutes. These changes dif-
fered significantly from the S group. The shortening of
the clotting time was paralleled by a significant increase
in MCF in the TS group, compared both to baseline
values and the S group (Figure 3).
Discussion
We report a significant reduction in ExTEM MCF in an-
imals exposed to haemorrhage during the trial period
(TS and S groups). Fibrinogen levels were also reduced
in these two groups. Despite this reduction, the animals
exposed to injury prior to exsanguination (TS group),
had a markedly increased fibrin based clotting activity
measured by a shortening of the clotting time and in-
creased maximum clot strength in the FibTEM assay.
Interestingly, INR and aPTT was also transiently affected
in a hypercoagulable direction in these animals. A simi-
lar trend towards increased clotting activity measured by
the FibTEM assay was observed in the group exposed to





























Time * Group: p=0.028
(B) over time for Trauma-Shock (TS) and Shock (S) groups, with
aseline in TS group. ¤ indicates significant difference from baseline in
Table 3 Coagulation analyses by RoTEM
Base line 0 minutes 30 minutes 60 minutes
ExTEM CT TS 112.7(49.70) 113.7 (24.3) 91.2 (29.8) 77.7 (16.9)
T 100.0 (23.8) 116.8 (39.2) 93.5 (22.5) 82.5 (15.6)
S 66.5 (12.4) 72.3 (8.0) 66.3 (3.9)
C 101.0 (41.0) 71.5 (10.6) 85.5 (5.0)
MCF TS 77.5 (3.9) 77.17 (3.2) 75.2 (3.2) 76.2 (4.3)
T 75.0 (2.6) 74.8 (2.4) 71.0 (8.7) 73.0 (1.4)
S 80.0 (2.5) 76.3 (3.8) 76.0 (2.2)
C 75.5 (3.5) 77.0 (2.8) 76.5 (3.5)
FibTEM CT TS 120.3 (31.5) 103.0 (28.4) 69.5 (11.8) 76.8 (16.1)
T 112.3 (56.4) 83.3 (24.6) 95.0 (19.1) 97.8 (47.5)
S 69.6 (14.3) 77.0 (14.9) 62.5 (9.7)
C 101.0 (41.0) 71.5 (10.6) 85.5 (5.0)
MCF TS 26.2 (23.6) 30.5 (24.9) 39.8 (18.0) 35.8 (19.7)
T 35.3 (24.7) 40.3 (15.6) 25.8 (18.8) 35.0 (18.1)
S 61.5 (6.5) 54.0 (6.8) 56.8 (4.0)
C 49.0 (2.8) 49.5 (10.6) 48.0 (7.1)
TS Trauma Shock group, T Trauma group, S Shock group, C control group,
CT Clotting time, MCF maximum clot firmness, Values are given as mean (SD).
Table 4 Coagulation analyses by RoTEM converted to
ratios of baseline values
Base line 0 minutes 30 minutes 60 minutes
ExTEM CT TS 1.0 (0.0) 1.18 (0.49) 1.0 (0.58) 0.77 (0.27)
T 1.0 (0.0) 1.16 (0.29) 1.02 (0.49) 0.86 (0.26)
S 1.0 (0.0) 1.12 (0.27) 1.04 (0.28)
C 1.0 (0.0) 0.79 (0.43) 0.91 (0.32)
MCF TS 1.0 (0.0) 1.0 (0.03) 0.97 (0.02)* 0.98 (0.02) †
T 1.0 (0.0) 1.0 (0.01) 0.95 (0.10) 0.97 (0.02)
S 1.0 (0.0) 0.95 (0.03) 0.95 (0.02)*†
C 1.0 (0.0) 1.02 (0.01) 1.01 (0.01)
FibTEM CT TS 1.0 (0.0) 0.91 (0.32) 0.64 (0.29)*† 0.66 (0.15)*†
T 1.0 (0.0) 0.95 (0.63) 1.08 (0.67) 0.97 (0.55)
S 1.0 (0.0) 1.14 (0.30)† 0.91 (0.11)†
C 1.0 (0.0) 0.79 (0.43) 0.91 (0.32)
MCF TS 1.0 (0.0) 1.19 (0.30) 1.89 (0.81)*† 1.59 (0.39)*†
T 1.0 (0.0) 1.45 (0.61) 0.93 (0.49) 1.15 (0.32)
S 1.0 (0.0) 0.88 (0.07)*† 0.93 (0.13)†
C 1.0 (0.0) 1.01 (0.16) 0.98 (0.09)
TS Trauma Shock group, T Trauma group, S Shock group, C Control group,
CT Clotting time, MCF maximum clot firmness, Values are given as mean ratios
of baseline values (SD).
* indicates significant change from baseline measured by paired t-test.
† indicates significant difference between TS and S groups by
two-sample t-test.
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only to haemorrhage.
Massive haemorrhage has previously been studied in
swine models [20-24], but only a few have studied the
effect of hypoperfusion in combination with soft tissue
injury and fractures in the initial phase prior to fluid re-
suscitation [25,26]. White et al. studied the effect on
conventional coagulation parameters as well as thrombe-
lastography using TEG, in a model of injured and hae-
morrhaged swine. As in our study they found a marked
reduction in fibrinogen levels, compared to the control
group, and a reduction in the maximum amplitude of
the clot strength. In one of the trials a significantly in-
creased INR was noted after trauma and shock. Neither
of these studies included assays specifically evaluating
the clotting activity after inhibition of platelets similar to
the FibTEM assay in our study.
Our study differs from most previous experimental
studies on coagulopathy in that the extent of tissue in-
jury inflicted is more extensive. In both studies by White
et al., tissue trauma was induced by using a captive bolt
pistol to cause a unilateral femoral fracture and soft tis-
sue trauma. In our study, both thighs were inflicted in-
jury from a high-energy rifle projectile, shattering the
femur and causing significant soft tissue damage. As-
suming the increased fibrin clotting capability is related
to the extent of trauma, this may explain why an in-
crease in INR in the TS group was not found in our
study.
Our study demonstrates a significant group*time dif-
ference in INR values, between the TS group and the S
group. As reported in several studies, INR measure-
ments are sensitive to fibrinogen activity [21,27]. The
group*time differences in INR may be a manifestation of
the same increased clotting activity seen in the FibTEM
assay for the TS group, caused by the extensive tissue
trauma.
Increased fibrin clot formation has previously been de-
scribed in a model of sheep undergoing intramedullary
nailing. The mechanism behind this is not entirely un-
derstood, but an association with intravasation of intra-
medullary fat has been demonstrated [28]. In a more
recent paper by Huseby et al., coagulation markers were
studied during intra-medullary reaming procedures in
swine [29]. They found a transient elevation of the
thrombin-antithrombin (TAT) complex as a surrogate
marker for increased thrombin activity. The rise in TAT
was unopposed by the fibrinolytic enzyme tissue plasmin
activator (t-PA), thus resulting in an enhanced fibrin
formation.
Several observational studies in human trauma pa-
tients describe a significant positive correlation between
fibrinogen concentration and FibTEM MCF values, di-
rectly contrasting the findings in our study [30]. There
01
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C D
Figure 3 Changes in RoTEM parameters over time as ratios of baseline, with mixed-models analyses. A) ExTEM clotting time (CT).
B) FibTEM CT. C) ExTEM maximum clot firmness and D) FibTEM MCF. * indicates significant difference from baseline in TS group. ¤ indicates
significant difference from baseline in S group. ¶ indicates differences between groups by two sample t-test. GSW: gunshot wound.
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man trials, fibrinogen levels in massively bleeding trauma
patients are typically lower than in our study [30]. The re-
duced fibrin availability may be the limiting factor of clot
formation. Secondly, acidaemia is frequently observed in
human trauma patients, and the offset from pH optimum
may affect the utilization of fibrinogen negatively. The
pH value in our animals remained in the normal range
throughout the experiment despite exsanguination.
Thirdly, our study did not include analyses of factor
XIII. This factor is known to be an important pre-
requisite in the inter-linkage of fibrin strands, and is
found to be reduced in human trauma patients [31].
This study has limitations related to the limited num-
ber of animals in each group. A type II error in the ana-
lyses cannot be ruled out. We used cytochalasin D to
inhibit platelets in the FibTEM assay in this study. The
reliability of this method was questioned in one previous
study, due to possible incomplete platelet inhibition [32].
The platelet count in our study was however not sig-
nificantly different between groups, and it is thereforeunlikely that this has imposed a systematic bias in our
analyses. The anaesthetic agents used may have had im-
plications for the findings in our study compared to what
is found in a human trauma population. Blocking of ad-
renergic response and vasodilatation may have affected
coagulation parameters, both due to direct catecholamine
effect and hypoperfusion. An alternative anaesthetic agent
such as ketamine to maintain catecholaminergic stimula-
tion could possibly have had implications for the results.
However, experience with ketamine in this setting is
sparse, and for ethical reasons, a well-established anaes-
thetic regimen securing adequate analgesia was chosen.
In conclusion, our animal model of shock and trauma
produced a hypocoagulable state measured by the ExTEM
assay. Despite this reduction in coagulation capability, and
a reduction in fibrinogen availability, a significant increase
in fibrin clotting activity was found to attenuate the
hypocoagulable effect of hypoperfusion in the pres-
ence of tissue injury. Further studies are required to
clarify the role of fibrin activity for research on trau-
matic coagulopathy.
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